Scientists discover how human brains grow larger than other apes
A study has discovered how humans develop larger brains than other apes.
Researchers identified a key molecular switch that can make ape brain organoids grow more like human organoids, and vice versa.
The study compared brain organoids – 3D tissues grown from stem cells which model early brain development – grown from human, gorilla and chimpanzee stem cells.
Researchers at the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge found that similar to actual brains, the human brain organoids grew a lot larger than those from other apes.
Dr Madeline Lancaster, from the MRC Laboratory of Molecular Biology, who led the study, said: “This provides some of the first insight into what is different about the developing human brain that sets us apart from our closest living relatives, the other great apes.
“The most striking difference between us and other apes is just how incredibly big our brains are.”
During the early stages of brain development, neurons are made by
You may also like
First-Of-Its-Kind Study Looks At Most Common Neurological Symptoms In COVID Long Haulers
MIAMI (CBSMiami) – A first-of-its-kind study looks at what neurological symptoms are most common in COVID-19 long haulers. The Northwestern Medicine study analyzed 100 long haulers with an average age of 43 who didn’t need to be hospitalized. Seventy percent were women and 85% reported experiencing four or more neurological symptoms including brain fog, headache, numbness/tingling, disorder of taste or smell, and muscle pain. “Forty-two percent said that they had some issues with anxiety and depression before COVID. It is possible that this plays a factor in some long COVID symptoms,” said Dr. Igor Koralnik, chief of Neuro-infectious Diseases & Global Neurology at Northwestern Medicine. Researchers also found 16% of patients had previous autoimmune diseases which could be another possible reason for long haul symptoms. And women are more likely to develop autoimmune diseases than men. Dr. Koralnik oversees the neuro COVID-19 clinic. He said research is under way to figure out the best way to manage and treat these lingering, debilitating symptoms. “I want them to know that help is on the way. Obviously, there are millions of people who have long COVID symptoms,” he said. Sara Buursma was a healthy mother of three before she got sick with COVID-19 last March. The 37 year-old has been dealing with many issues for the last year, from shortness of breath to brain fog. “It’s scary. I don’t know what’s going on with my health. I’ve never had health issues. I was always a very active person,” she said. Her brain fog and shortness of breath are improving with medication. “Don’t settle for someone that, you know, might not know what you’re going through or thinks that maybe it’s just in your head. Well, it’s not. Every person in this world deserves the best care and deserves to get their health back,” she said. Buursma also said don’t lose hope. She has her sights set on running the Chicago marathon next year. Neurological SymptomsLong HaulCovid-19Public HealthDepression SymptomsBrain DiseasesPain MedicationBrain HealthBrain ResearchCBSMiamiCOVIDAutoimmune DiseasesDisorderMuscle PainHealth Issues
New AstraZeneca report says vaccine was 76% effective in preventing Covid-19 symptoms
Drug giant AstraZeneca updated its data on how well its coronavirus vaccine works, saying late Wednesday the vaccine showed 76% efficacy against symptomatic coronavirus disease and 100% efficacy against severe or critical disease or the need for hospitalization. The vaccine was 85% effective in preventing symptoms in volunteers 65 and...Read Full StoryAstrazenecaCovid-19 VaccinePublic HealthVaccine DosesDrug ResearchAllergy SymptomsDSMBNIAIDABCGood Morning AmericaUniversity Of OxfordDrug Giant AstraZenecaCovid-29 SymptomsVaccine HesitancyNeurological SymptomsMene PangalosAnthony Fauci
WTTC records US$4.5 trillion in tourism losses for 2020
An economic impact report (EIR) from the World Travel & Tourism Council has revealed the full impact of Covid-19 on global tourism. The body argues the sector suffered a loss of almost US$4.5 trillion last year. The annual research shows tourism’s contribution to GDP dropped a staggering 49 per cent...Read Full StoryWorld EconomyGlobal EconomyMarketsGlobal GdpDomestic TourismGlobal ImpactWTTC RecordsWTTC ResearchWTTC Chief ExecutiveGlobal TourismVast LossesGlobal GDPDomestic Travel SpendingEconomic ImpactJobsGloria Guevara
Surgical Fixators Market Restraints, Trends, Opportunities, Growth and PESTEL Analysis (2022-2031)
Market.us updated new market research study work on “Surgical Fixators Market“, where users can benefit from the complete market research report with all the required useful information about this market. The report also focuses on the major driving trends and challenges that affect the market and the vendor landscape. Today’s...Read Full StoryMarket TrendsMarket ResearchMarket CompetitionMarket SegmentsMarketsMarket DemandBusiness ResearchAdvanced ManufacturingPESTEL AnalysisMarket.usEnergy & UtilityMetal MaterialThe Middle East & AfricaNorth AmericanMedtronic PLC
Electrophysiology Therapeutic Devices Market Industry Survey, Comprehensive Insights and Massive Growth (2022-2031)
Market.us updated new market research study work on “Electrophysiology Therapeutic Devices Market“, where users can benefit from the complete market research report with all the required useful information about this market. The report also focuses on the major driving trends and challenges that affect the market and the vendor landscape.Read Full StoryMarket ResearchMarket CompetitionMarket TrendsMarket SegmentsMarketsBusiness ResearchAdvanced ManufacturingHealth Services ResearchComprehensive InsightsMarket.usEnergy & UtilityMetal MaterialThe Middle East & AfricaNorth AmericanAgito Medical
AC Current Transformers (CT) for Electrical Meters Market 2020 In-Depth Analysis and Future Forecast 2020-2026 | Key Players include VAC, Falco, J&D Electronics Co.,Ltd, etc.
The AC Current Transformers (CT) for Electrical Meters market report is a detailed summary of the present market scenario and how it is likely to shape up in the forecast years. The ’AC Current Transformers (CT) for Electrical Meters market’ is evaluated on the basis of two segments i.e., by type and by application, encompassing the essential statistics and details for present-day and future market scenarios. The report includes relevant data concerning the drivers and restraints which are derived through SWOT analysis.Read Full StoryMarket AnalysisKey MarketVacMarket DataData AnalysisPerformance AnalysisConsumer ElectronicsVACCrompton InstrumentsAccuenergyOmegaFlex-CorePinAcquire Market ResearchMarket Research Reports
Delivery Hero SE (ETR:DHER) Receives Average Recommendation of “Buy” from Brokerages
Shares of Delivery Hero SE (ETR:DHER) have been given a consensus rating of “Buy” by the thirteen brokerages that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is €138.58 ($163.04).Read Full StoryEtrMoving AverageEuropeJpmorgan Chase & Co.MarketsAverage Price TargetTarget PriceStock PriceSell-Side AnalystsResearch AnalystsRoyal Bank Of CanadaBank Of AmericaUBS GroupJPMorgan Chase & Co.ETR
Baird Financial Group Inc. Buys New Holdings in Schrödinger, Inc. (NASDAQ:SDGR)
Baird Financial Group Inc. purchased a new position in Schrödinger, Inc. (NASDAQ:SDGR) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,364 shares of the company’s stock, valued at approximately $266,000. A number of other...Read Full StorySdgrFinancial AdvisorsNasdaqNASDAQ Inc.EquityZacks Investment ResearchStock InvestorsInvestment AnalystsNew HoldingsSECSignaturefd LLCCWM LLCSVP Jennifer DanielSchrödinger , Inc.BMO Capital Markets
Portland General Electric (NYSE:POR) Upgraded at The Goldman Sachs Group
POR has been the topic of several other research reports. TheStreet upgraded shares of Portland General Electric from a c+ rating to a b rating in a report on Friday, February 19th. Zacks Investment Research lowered Portland General Electric from a buy rating to a hold rating in a research note on Friday, March 12th. Finally, KeyCorp upgraded Portland General Electric from a sector weight rating to an overweight rating and set a $49.00 target price for the company in a research note on Tuesday, January 12th. Six equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock has an average rating of Hold and a consensus target price of $44.30.Read Full StoryGoldman Sachs GroupNyseMarketsNYSEZacks Investment ResearchStock PriceInvestment AnalystsPORTheStreetKeyCorpHoldBlackRock Inc.Norges BankTruist Financial Corp NowKilovoltMa
Morgan Stanley Lowers Plains GP (NYSE:PAGP) to Equal Weight
Several other equities analysts have also commented on the company. Barclays lowered their price objective on Plains GP from $12.00 to $11.00 and set an equal weight rating for the company in a research report on Friday, March 19th. Zacks Investment Research cut shares of Plains GP from a hold rating to a strong sell rating in a research report on Wednesday, March 17th. Mizuho upped their price objective on shares of Plains GP from $13.00 to $14.00 and gave the stock a buy rating in a report on Wednesday, January 20th. Raymond James lifted their target price on shares of Plains GP from $9.00 to $12.00 and gave the company an outperform rating in a report on Thursday, January 14th. Finally, Scotiabank initiated coverage on Plains GP in a research report on Monday, February 1st. They issued an outperform rating on the stock. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus target price of $11.42.Read Full StoryNysePagpCanadaMarketsNYSEStock PriceZacks Investment ResearchAverage Price TargetBarclaysPlains GP 'sOTA Financial Group L.P.Jennison Associates LLCSupply And LogisticsScotiabankMarketBeat.com
Barclays PLC Acquires 711 Shares of Columbus McKinnon Co. (NASDAQ:CMCO)
Barclays PLC boosted its stake in shares of Columbus McKinnon Co. (NASDAQ:CMCO) by 4.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 18,123 shares of the industrial products company’s stock after buying an additional 711 shares during the period. Barclays PLC owned approximately 0.08% of Columbus McKinnon worth $696,000 as of its most recent filing with the SEC.Read Full StoryBarclays PlcCmcoMotion ControlNasdaqMarketsNASDAQ Inc.Zacks Investment ResearchStock InvestorsStock FundsBarclays PLC AcquiresColumbus McKinnon Co.CMCOSECSei Investments Co.Swiss National Bank